CatalystFDA/Bio

CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology

Publication of pivotal Phase 3 BOND-003 results in The Lancet Oncology signals key clinical milestone.

What changed

Publication of pivotal Phase 3 BOND-003 results in The Lancet Oncology signals key clinical milestone.

Why it matters

Publication of pivotal Phase 3 BOND-003 results in The Lancet Oncology signals key clinical milestone. — impact context not separately stored; see What changed.

Sources

eodhd